Vestrant 250 mg Injection
192,66$
150,28$
Vestrant 250 mg injection is a targeted anticancer treatment designed specifically for postmenopausal women battling breast cancer. This medication is particularly effective in managing hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, especially in cases that are locally advanced or metastatic, and may be used in conjunction with palbociclib following prior endocrine therapy. Vestrant operates by diminishing estrogen levels in the body, which is crucial as many breast cancers rely on this hormone for growth. While Vestrant can be a vital component of cancer therapy, it's essential for patients to be aware of potential side effects and to discuss any concerns with their healthcare provider. Regular monitoring during treatment is advised to ensure optimal results and to manage any adverse reactions effectively. As with any anticancer medication, understanding how Vestrant fits into a comprehensive treatment plan is key for achieving the best possible outcomes. Consult your doctor for personalized guidance and to explore the full benefits of Vestrant in your breast cancer treatment journey.
Quantité
Active Pharmaceutical Ingredient
Uses
• Vestrant 250 mg injection is primarily utilized in the treatment of certain types of breast cancer. It helps manage symptoms associated with the disease, which may include the presence of lumps or abnormal thickening in the breast or underarm area. This targeted approach can significantly improve the quality of life for patients undergoing treatment. By addressing these symptoms, Vestrant 250 mg injection plays a crucial role in the overall management of breast cancer.
• In addition to alleviating symptoms, Vestrant 250 mg injection is often used to slow down the progression of breast cancer. This can be particularly beneficial for patients with advanced stages of the disease. By inhibiting cancer cell growth, Vestrant 250 mg injection allows for better control over the condition. This can lead to improved outcomes and extended survival rates for those affected.
• Vestrant 250 mg injection is also indicated for patients who have experienced a recurrence of breast cancer. In such cases, it can help to manage the re-emergence of symptoms and provide relief. This makes Vestrant 250 mg injection a valuable option for individuals navigating the complexities of recurrent breast cancer. The injection supports ongoing treatment plans, allowing patients to maintain their daily activities with reduced discomfort.
• Healthcare providers may recommend Vestrant 250 mg injection as part of a comprehensive treatment strategy for breast cancer. It is often used in conjunction with other therapies to enhance overall effectiveness. By integrating Vestrant 250 mg injection into their treatment regimen, patients may experience a more holistic approach to managing their condition. This collaborative effort aims to improve both physical and emotional well-being during the cancer journey.
Benefits
Vestrant Injection effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Vestrant 250 Injection by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.
Side Effects
As with all medicines, Vestrant 250 mg Injection may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract
Common Side Effects
• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face
How To Use
The Vestrant 250 mg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Vestrant 250 mg Injection will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Vestrant 250 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Vestrant 250 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Vestrant Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Vestrant 250 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Vestrant 250 mg Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Vestrant 250 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Vestrant 250 Injection. Vestrant Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Vestrant 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Vestrant 250 Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Vestrant 250 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Vestrant 250 Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Vestrant 250 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Vestrant 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Vestrant 250 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Vestrant 250 Injection such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.